HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NCSTN
nicastrin
Chromosome 1 Β· 1q23.2
NCBI Gene: 23385Ensembl: ENSG00000162736.18HGNC: HGNC:17091UniProt: A0A8V8TPQ8
204PubMed Papers
21Diseases
7Drugs
23Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
Trending
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
membraneprotein bindingprotein-macromolecule adaptor activityATPase bindingacne inversa, familial, 1neurodegenerative diseaseDesmoid-type fibromatosisneoplasm
✦AI Summary

NCSTN (nicastrin) encodes an essential scaffolding subunit of the gamma-secretase complex, a multiprotein endoprotease that catalyzes intramembrane cleavage of integral membrane proteins including Notch receptors and amyloid-beta precursor protein (APP) 12. Through its role in this complex, NCSTN regulates Notch and Wnt/Ξ²-catenin signaling cascades critical for epidermal keratinization and hair follicle development 34. Mechanistically, NCSTN functions as a membrane-anchored adaptor protein within gamma-secretase, facilitating substrate recognition and catalytic processing. Loss-of-function NCSTN mutations impair hair follicle structure and keratinocyte differentiation, reducing expression of hair cortex cytokeatin and trichohyalin 4. Clinically, NCSTN mutations are associated with hidradenitis suppurativa (HS)/acne inversa, a chr1 inflammatory skin disease characterized by follicular occlusion and destructive lesions 53. NCSTN variants account for a subset of familial HS cases, with carriers showing earlier disease onset and distinctive phenotypes involving atypical sites (scalp, neck, torso) 6. NCSTN mutations also cause Dowling Degos disease, a reticulated pigmentation disorder, often comorbid with HS 7. These findings establish NCSTN as a major genetic determinant in dermatologic disease pathogenesis through disrupted epidermal differentiation pathways.

Sources cited
1
NCSTN is an essential subunit of gamma-secretase complex catalyzing intramembrane cleavage of Notch and APP
PMID: 10993067
2
NCSTN functions in gamma-secretase-mediated proteolysis of integral membrane proteins
PMID: 12679784
3
NCSTN mutations associate with hidradenitis suppurativa and map to Notch/Wnt signaling pathways involved in epidermal keratinization
PMID: 39645042
4
NCSTN mutations cause abnormal hair follicle structure and reduced expression of hair keratins and trichohyalin, leading to HS-like lesions
PMID: 35843211
5
Loss-of-function NCSTN mutations identified in familial acne inversa/hidradenitis suppurativa, implicating gamma-secretase-Notch pathway
PMID: 20929727
6
NCSTN deletion variants in HS patients show earlier disease onset and atypical phenotypic presentation affecting scalp, neck, and torso
PMID: 37494055
7
NCSTN nonsense mutations cause haploinsufficiency and are associated with both Dowling Degos disease and hidradenitis suppurativa
PMID: 37665193
Disease Associationsβ“˜21
acne inversa, familial, 1Open Targets
0.72Strong
neurodegenerative diseaseOpen Targets
0.53Moderate
Desmoid-type fibromatosisOpen Targets
0.48Moderate
neoplasmOpen Targets
0.41Moderate
Alzheimer diseaseOpen Targets
0.39Weak
hidradenitis suppurativaOpen Targets
0.38Weak
Pyoderma gangrenosum-acne-suppurative hidradenitis syndromeOpen Targets
0.37Weak
Abnormality of the skinOpen Targets
0.34Weak
Parkinson diseaseOpen Targets
0.26Weak
Follicular CystOpen Targets
0.24Weak
skin diseaseOpen Targets
0.22Weak
skin appendage disorderOpen Targets
0.21Weak
genetic disorderOpen Targets
0.19Weak
breast cancerOpen Targets
0.11Weak
multiple myelomaOpen Targets
0.11Weak
carbuncleOpen Targets
0.10Weak
Cutaneous abscessOpen Targets
0.10Weak
FuruncleOpen Targets
0.10Weak
sebaceous gland diseaseOpen Targets
0.10Suggestive
non-small cell lung carcinomaOpen Targets
0.10Suggestive
Acne inversa, familial, 1UniProt
Pathogenic Variants23
NM_015331.3(NCSTN):c.996+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2026
NM_015331.3(NCSTN):c.436+1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_015331.3(NCSTN):c.1258C>T (p.Gln420Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 420
NM_015331.3(NCSTN):c.751_752del (p.Leu251fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 251
NM_015331.3(NCSTN):c.1654del (p.Gln552fs)Likely pathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†2024β†’ Residue 552
NM_015331.3(NCSTN):c.1294C>T (p.Arg432Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 432
NM_015331.3(NCSTN):c.278dup (p.Tyr94fs)Likely pathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†2023β†’ Residue 94
NM_015331.3(NCSTN):c.436+1G>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2023
NM_015331.3(NCSTN):c.1101_1101+17delinsTGTCCAPathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†2022
NM_015331.3(NCSTN):c.1118C>G (p.Ser373Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 373
NM_015331.3(NCSTN):c.1352+1G>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_015331.3(NCSTN):c.1290del (p.Leu431fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2021β†’ Residue 431
NM_015331.3(NCSTN):c.1635C>G (p.Tyr545Ter)Pathogenic
Abnormality of the skin
β˜…β˜†β˜†β˜†2021β†’ Residue 545
NM_015331.3(NCSTN):c.17del (p.Gly6fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 6
NM_015331.3(NCSTN):c.214del (p.Val72fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2017β†’ Residue 72
NM_015331.3(NCSTN):c.1300C>T (p.Arg434Ter)Pathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†2016β†’ Residue 434
NM_015331.3(NCSTN):c.579del (p.Lys193fs)Likely pathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†β†’ Residue 193
NM_015331.3(NCSTN):c.349C>T (p.Arg117Ter)Pathogenic
Acne inversa, familial, 1
β˜…β˜†β˜†β˜†β†’ Residue 117
NM_015331.3(NCSTN):c.97G>A (p.Gly33Arg)Pathogenic
Acne inversa, familial, 1
β˜†β˜†β˜†β˜†2024β†’ Residue 33
NM_015331.3(NCSTN):c.1285C>T (p.Arg429Ter)Pathogenic
Acne inversa, familial, 1
β˜†β˜†β˜†β˜†2021β†’ Residue 429
View on ClinVar β†—
Drug Targets7
AVAGACESTATPhase II
Gamma-secretase inhibitor
Alzheimer disease
BEGACESTATPhase I
Gamma-secretase inhibitor
Alzheimer disease
NIROGACESTATApproved
Gamma-secretase inhibitor
NIROGACESTAT HYDROBROMIDEApproved
Gamma-secretase inhibitor
RG-4733Phase II
Gamma-secretase inhibitor
breast cancer
SEMAGACESTATPhase III
Gamma-secretase inhibitor
Parkinson disease
TARENFLURBILPhase III
Gamma-secretase modulator
Alzheimer disease
Related Genes
TMED10Protein interaction100%APEHProtein interaction91%MMEL1Protein interaction89%RHBDL2Protein interaction89%CDH1Protein interaction88%APPProtein interaction87%
Tissue Expression6 tissues
Heart
100%
Lung
98%
Ovary
84%
Brain
74%
Bone Marrow
64%
Liver
63%
Gene Interaction Network
Click a node to explore
NCSTNTMED10APEHMMEL1RHBDL2CDH1APP
PROTEIN STRUCTURE
Preparing viewer…
PDB8KCS Β· 2.40 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.34Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.24 [0.17–0.34]
RankingsWhere NCSTN stands among ~20K protein-coding genes
  • #2,060of 20,598
    Most Researched204 Β· top quartile
  • #558of 1,025
    FDA-Approved Drug Targets2
  • #2,040of 5,498
    Most Pathogenic Variants23
  • #1,489of 17,882
    Most Constrained (LOEUF)0.34 Β· top 10%
Genes detectedNCSTN
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Identification and validation of a signature based on macrophage cell marker genes to predict recurrent miscarriage by integrated analysis of single-cell and bulk RNA-sequencing.
PMID: 36439123
Front Immunol Β· 2022
1.00
2
Identification and verification of diagnostic biomarkers in recurrent pregnancy loss via machine learning algorithm and WGCNA.
PMID: 37691920
Front Immunol Β· 2023
0.90
3
The combination between
PMID: 32208881
Anim Biotechnol Β· 2021
0.80
4
A genome-wide association meta-analysis links hidradenitis suppurativa to common and rare sequence variants causing disruption of the Notch and Wnt/Ξ²-catenin signaling pathways.
PMID: 39645042
J Am Acad Dermatol Β· 2025
0.70
5
A Novel NCSTN Mutation in a Three-Generation Chinese Family with Hidradenitis Suppurative.
PMID: 35368949
J Healthc Eng Β· 2022
0.68